Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

775 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decision support systems for personalized and participative radiation oncology.
Lambin P, Zindler J, Vanneste BG, De Voorde LV, Eekers D, Compter I, Panth KM, Peerlings J, Larue RT, Deist TM, Jochems A, Lustberg T, van Soest J, de Jong EE, Even AJ, Reymen B, Rekers N, van Gisbergen M, Roelofs E, Carvalho S, Leijenaar RT, Zegers CM, Jacobs M, van Timmeren J, Brouwers P, Lal JA, Dubois L, Yaromina A, Van Limbergen EJ, Berbee M, van Elmpt W, Oberije C, Ramaekers B, Dekker A, Boersma LJ, Hoebers F, Smits KM, Berlanga AJ, Walsh S. Lambin P, et al. Adv Drug Deliv Rev. 2017 Jan 15;109:131-153. doi: 10.1016/j.addr.2016.01.006. Epub 2016 Jan 14. Adv Drug Deliv Rev. 2017. PMID: 26774327 Review.
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, De Ruysscher D. van Der Wel A, et al. Among authors: lambin p. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):649-55. doi: 10.1016/j.ijrobp.2004.06.205. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708242
Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study.
De Ruysscher D, Wanders S, Minken A, Lumens A, Schiffelers J, Stultiens C, Halders S, Boersma L, Baardwijk Av, Verschueren T, Hochstenbag M, Snoep G, Wouters B, Nijsten S, Bentzen SM, Kroonenburgh Mv, Ollers M, Lambin P. De Ruysscher D, et al. Among authors: lambin p. Radiother Oncol. 2005 Oct;77(1):5-10. doi: 10.1016/j.radonc.2005.06.014. Epub 2005 Jul 12. Radiother Oncol. 2005. PMID: 16019093 Clinical Trial.
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.
De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, Hochstenbag M, Boersma L, Wouters B, Lammering G, Vansteenkiste J, Lambin P. De Ruysscher D, et al. Among authors: lambin p. J Clin Oncol. 2006 Mar 1;24(7):1057-63. doi: 10.1200/JCO.2005.02.9793. J Clin Oncol. 2006. PMID: 16505424
Prone breast irradiation for pendulous breasts.
Buijsen J, Jager JJ, Bovendeerd J, Voncken R, Borger JH, Boersma LJ, Murrer LH, Lambin P. Buijsen J, et al. Among authors: lambin p. Radiother Oncol. 2007 Mar;82(3):337-40. doi: 10.1016/j.radonc.2006.08.014. Epub 2006 Sep 15. Radiother Oncol. 2007. PMID: 16978722
Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study.
Bosmans G, van Baardwijk A, Dekker A, Ollers M, Boersma L, Minken A, Lambin P, De Ruysscher D. Bosmans G, et al. Among authors: lambin p. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):748-53. doi: 10.1016/j.ijrobp.2006.05.022. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011450
775 results